暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
为什么 Nucor 股价走低?以下是周二午盘交易中其他股票的走势
纽柯公司(纽约证券交易所代码:NUE)的股价在周二的交易日大幅下跌,此前该公司公布的季度财务业绩低于预期。纽柯公布的季度收益为每秒3.46美元
Benzinga04/23 13:53 (美东)
快讯 | 卡梅尔宣布成功完成300万美元的私募配售
Moomoo 24/704/11 16:30 (美东)
快讯 | 卡梅尔宣布以每股普通股2.25澳元的价格私募约1,333,333股普通股进行300万美元私募后,该公司股价走低
Moomoo 24/704/04 13:00 (美东)
周四盘中交易时段,12只医疗保健类股走势
在周四的例会中,GainersScandel Therapeutics(纳斯达克股票代码:CADL)股价上涨了64.3%,至2.76美元。他们已发行股票的市值为8,090万美元。TC BioPharm(控股)
Benzinga04/04 12:31 (美东)
卡梅尔宣布私募300万澳元
匹兹堡,2024年4月4日(GLOBE NEWSWIRE)——专注于皮肤和头发健康的生物美容公司卡梅尔公司(纳斯达克股票代码:CTCX)(“Carmell”,“公司”,“我们”,“我们” 或 “我们”)今天宣布
GlobeNewswire04/04 08:30 (美东)
卡梅尔宣布成功完成Axolotl Biologix销售交易
匹兹堡,2024年3月27日(GLOBE NEWSWIRE)——专注于皮肤和头发健康的生物美容公司卡梅尔公司(纳斯达克股票代码:CTCX)(“Carmell”,“公司”,“我们”,“我们” 或 “我们”)今天宣布
GlobeNewswire03/27 09:15 (美东)
BBES : It means the price going to low. You can buy when it hit low price
Trytosaveabit楼主 BBES: Means the company just got 3 million dollars and didn’t have to take a loan! Helps continue operations! Also right now there is almost no volume! I posted because it could be a good place to look to enter for a swing trade?? Someone paid 3 million and I’m sure it wasn’t without expecting a return on investment? NFA GL
BBES Trytosaveabit楼主: Just buy when it’s low.
Trytosaveabit楼主 BBES: I will scale in! That way if it drops more? I can average down without spending more than what I was planning and still bring my average down if need be! Just like scaling out on the way up to protect profits and drop diluted cost allowing me to absorb bigger pullbacks while remaining in profit
BBES : Hey time to buy now.
Jaguar8 : No sell?
Trytosaveabit楼主 Jaguar8: It seems from all available data that I can find. All sell went straight to DP to probably be used for SS’s? JMO
Jaguar8 Trytosaveabit楼主: Grrr
Trytosaveabit楼主 Jaguar8: I know right! Like I said DP started as a well intentioned good thing! But it has turned into a place where corruption is made super easy and in the dark! And also now the norm! The way to hell is paved with good intentions! Hehehe
Jaguar8 Trytosaveabit楼主: How do they get into dark pool?
Trytosaveabit楼主 :
Following the sale of AxoBio, Carmell's financial position is expected to improve as follows:
$4 million drop in annualized cash burn (net of revenue) based on AxoBio's actual January 2024 financials.
$15.6 million reduction in debt: $7.6 million of AxoBio subsidiary level debt plus $8 million note payable related to the AxoBio acquisition.
$7 million increase in tangible equity due to elimination of AxoBio's negative tangible equity.
29% reduction in EPS dilution due to the return of 8.09 million CTCX common shares on a fully diluted basis. After closing, Carmell will have 19.25 million common shares outstanding.
Trytosaveabit楼主 : Oh yeah! And look at the daily chart since post in November! Hehehe
暂无数据
暂无数据
BBES : Time to buy